nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethanolamine Oleate—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.121	1	CbGbCtD
Ethanolamine Oleate—F12—blood plasma—acquired immunodeficiency syndrome	0.055	0.131	CbGeAlD
Ethanolamine Oleate—Bacteraemia—Zidovudine—acquired immunodeficiency syndrome	0.0466	0.103	CcSEcCtD
Ethanolamine Oleate—Bacteraemia—Indinavir—acquired immunodeficiency syndrome	0.0434	0.096	CcSEcCtD
Ethanolamine Oleate—FABP5—skin of body—acquired immunodeficiency syndrome	0.0225	0.0534	CbGeAlD
Ethanolamine Oleate—FABP4—skin of body—acquired immunodeficiency syndrome	0.021	0.05	CbGeAlD
Ethanolamine Oleate—F12—blood—acquired immunodeficiency syndrome	0.0202	0.0479	CbGeAlD
Ethanolamine Oleate—Oesophageal ulcer—Ritonavir—acquired immunodeficiency syndrome	0.0199	0.0442	CcSEcCtD
Ethanolamine Oleate—F12—bone marrow—acquired immunodeficiency syndrome	0.0195	0.0463	CbGeAlD
Ethanolamine Oleate—Oesophageal ulcer—Saquinavir—acquired immunodeficiency syndrome	0.0192	0.0425	CcSEcCtD
Ethanolamine Oleate—F12—vagina—acquired immunodeficiency syndrome	0.0187	0.0444	CbGeAlD
Ethanolamine Oleate—Retrosternal pain—Ritonavir—acquired immunodeficiency syndrome	0.0181	0.04	CcSEcCtD
Ethanolamine Oleate—FABP5—digestive system—acquired immunodeficiency syndrome	0.018	0.0427	CbGeAlD
Ethanolamine Oleate—Retrosternal pain—Saquinavir—acquired immunodeficiency syndrome	0.0174	0.0385	CcSEcCtD
Ethanolamine Oleate—FABP5—blood—acquired immunodeficiency syndrome	0.0171	0.0407	CbGeAlD
Ethanolamine Oleate—FABP4—lymphoid tissue—acquired immunodeficiency syndrome	0.017	0.0405	CbGeAlD
Ethanolamine Oleate—FABP4—digestive system—acquired immunodeficiency syndrome	0.0168	0.04	CbGeAlD
Ethanolamine Oleate—FABP5—spinal cord—acquired immunodeficiency syndrome	0.0165	0.0392	CbGeAlD
Ethanolamine Oleate—FABP4—bone marrow—acquired immunodeficiency syndrome	0.0155	0.0368	CbGeAlD
Ethanolamine Oleate—FABP5—lung—acquired immunodeficiency syndrome	0.015	0.0357	CbGeAlD
Ethanolamine Oleate—FABP4—vagina—acquired immunodeficiency syndrome	0.0149	0.0353	CbGeAlD
Ethanolamine Oleate—Necrosis—Nevirapine—acquired immunodeficiency syndrome	0.0142	0.0315	CcSEcCtD
Ethanolamine Oleate—FABP4—lung—acquired immunodeficiency syndrome	0.0141	0.0334	CbGeAlD
Ethanolamine Oleate—FABP5—nervous system—acquired immunodeficiency syndrome	0.0139	0.033	CbGeAlD
Ethanolamine Oleate—FABP5—central nervous system—acquired immunodeficiency syndrome	0.0134	0.0318	CbGeAlD
Ethanolamine Oleate—FABP4—nervous system—acquired immunodeficiency syndrome	0.013	0.0309	CbGeAlD
Ethanolamine Oleate—F12—brain—acquired immunodeficiency syndrome	0.0125	0.0297	CbGeAlD
Ethanolamine Oleate—Ulcer—Nevirapine—acquired immunodeficiency syndrome	0.0118	0.0261	CcSEcCtD
Ethanolamine Oleate—FABP5—brain—acquired immunodeficiency syndrome	0.0106	0.0253	CbGeAlD
Ethanolamine Oleate—Necrosis—Efavirenz—acquired immunodeficiency syndrome	0.0105	0.0232	CcSEcCtD
Ethanolamine Oleate—FABP5—lymph node—acquired immunodeficiency syndrome	0.0103	0.0244	CbGeAlD
Ethanolamine Oleate—Necrosis—Delavirdine—acquired immunodeficiency syndrome	0.01	0.0222	CcSEcCtD
Ethanolamine Oleate—FABP4—brain—acquired immunodeficiency syndrome	0.00995	0.0236	CbGeAlD
Ethanolamine Oleate—Abscess—Delavirdine—acquired immunodeficiency syndrome	0.00994	0.022	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Didanosine—acquired immunodeficiency syndrome	0.00975	0.0216	CcSEcCtD
Ethanolamine Oleate—FABP4—lymph node—acquired immunodeficiency syndrome	0.00961	0.0228	CbGeAlD
Ethanolamine Oleate—Abscess—Saquinavir—acquired immunodeficiency syndrome	0.00885	0.0196	CcSEcCtD
Ethanolamine Oleate—Ulcer—Efavirenz—acquired immunodeficiency syndrome	0.00869	0.0193	CcSEcCtD
Ethanolamine Oleate—Ulcer—Delavirdine—acquired immunodeficiency syndrome	0.00832	0.0184	CcSEcCtD
Ethanolamine Oleate—Ulcer—Saquinavir—acquired immunodeficiency syndrome	0.0074	0.0164	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Delavirdine—acquired immunodeficiency syndrome	0.00719	0.0159	CcSEcCtD
Ethanolamine Oleate—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.00716	0.017	CbGeAlD
Ethanolamine Oleate—Renal failure acute—Indinavir—acquired immunodeficiency syndrome	0.00684	0.0152	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Ritonavir—acquired immunodeficiency syndrome	0.00665	0.0147	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Efavirenz—acquired immunodeficiency syndrome	0.00646	0.0143	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Saquinavir—acquired immunodeficiency syndrome	0.0064	0.0142	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Delavirdine—acquired immunodeficiency syndrome	0.00619	0.0137	CcSEcCtD
Ethanolamine Oleate—Sodium lauryl sulfate—ALB—acquired immunodeficiency syndrome	0.00616	1	CrCbGaD
Ethanolamine Oleate—Pneumonia—Nelfinavir—acquired immunodeficiency syndrome	0.00608	0.0135	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Abacavir—acquired immunodeficiency syndrome	0.00597	0.0132	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Ritonavir—acquired immunodeficiency syndrome	0.00572	0.0127	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Saquinavir—acquired immunodeficiency syndrome	0.00551	0.0122	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Indinavir—acquired immunodeficiency syndrome	0.0049	0.0108	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Efavirenz—acquired immunodeficiency syndrome	0.00463	0.0102	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Delavirdine—acquired immunodeficiency syndrome	0.00443	0.0098	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.00442	0.0098	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.00398	0.00881	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Saquinavir—acquired immunodeficiency syndrome	0.00394	0.00872	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.00378	0.00838	CcSEcCtD
Ethanolamine Oleate—Pain—Didanosine—acquired immunodeficiency syndrome	0.00378	0.00838	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.0035	0.00775	CcSEcCtD
Ethanolamine Oleate—Chest pain—Zidovudine—acquired immunodeficiency syndrome	0.00348	0.00771	CcSEcCtD
Ethanolamine Oleate—Pain—Nevirapine—acquired immunodeficiency syndrome	0.0034	0.00753	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00334	0.00739	CcSEcCtD
Ethanolamine Oleate—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.00329	0.0073	CcSEcCtD
Ethanolamine Oleate—Pain—Stavudine—acquired immunodeficiency syndrome	0.00328	0.00727	CcSEcCtD
Ethanolamine Oleate—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.00324	0.00717	CcSEcCtD
Ethanolamine Oleate—Pain—Abacavir—acquired immunodeficiency syndrome	0.00324	0.00717	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.00314	0.00696	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.0031	0.00688	CcSEcCtD
Ethanolamine Oleate—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.00306	0.00678	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00305	0.00674	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00304	0.00672	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00299	0.00662	CcSEcCtD
Ethanolamine Oleate—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.00293	0.00648	CcSEcCtD
Ethanolamine Oleate—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00285	0.00632	CcSEcCtD
Ethanolamine Oleate—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.00279	0.00662	CbGeAlD
Ethanolamine Oleate—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.00276	0.00654	CbGeAlD
Ethanolamine Oleate—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00271	0.006	CcSEcCtD
Ethanolamine Oleate—Pain—Indinavir—acquired immunodeficiency syndrome	0.00266	0.00588	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00264	0.00584	CcSEcCtD
Ethanolamine Oleate—CYP2E1—blood—acquired immunodeficiency syndrome	0.00262	0.00623	CbGeAlD
Ethanolamine Oleate—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.00261	0.00577	CcSEcCtD
Ethanolamine Oleate—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.00253	0.006	CbGeAlD
Ethanolamine Oleate—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00251	0.00556	CcSEcCtD
Ethanolamine Oleate—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.00249	0.00551	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00245	0.00544	CcSEcCtD
Ethanolamine Oleate—Pain—Delavirdine—acquired immunodeficiency syndrome	0.0024	0.00532	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00238	0.00528	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00232	0.00514	CcSEcCtD
Ethanolamine Oleate—CYP2E1—lung—acquired immunodeficiency syndrome	0.0023	0.00546	CbGeAlD
Ethanolamine Oleate—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00222	0.00492	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.00222	0.00491	CcSEcCtD
Ethanolamine Oleate—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00214	0.00473	CcSEcCtD
Ethanolamine Oleate—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.00213	0.00506	CbGeAlD
Ethanolamine Oleate—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00205	0.00454	CcSEcCtD
Ethanolamine Oleate—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.00205	0.00487	CbGeAlD
Ethanolamine Oleate—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00204	0.00451	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00197	0.00437	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00188	0.00417	CcSEcCtD
Ethanolamine Oleate—CYP2E1—brain—acquired immunodeficiency syndrome	0.00163	0.00387	CbGeAlD
